Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:21 PM
Ignite Modification Date:
2025-12-24 @ 2:21 PM
NCT ID:
NCT02516995
Eligibility Criteria:
Inclusion Criteria:
Patients with prostate cancer biopsy-proven, intermediate or high risk (according to D'Amico Classification), for which radiotherapy is indicated.
* Accepting the imaging tests.
* Age \<70 years.
* Informed consent signed.
Exclusion Criteria:
* Mental pathology that can interfere with the proper conduct of the study;
* Claustrophobia;
* Severe heart or respiratory disorder that can make it difficult to achieve relatively long imaging tests
* Contraindications to magnetic resonance imaging (MRI)
1. pacemaker, other electronic appliance (depending on model);
2. heart valve, intra-cranial clip aneurysm, cerebral ventricular bypass valve (depending on model);
3. intraocular metallic foreign bodies (chips), and other locations, according to the site to discuss.
4. metal tracheostomy cannula;
5. endovascular stent or vascular embolization coils placed within six weeks in advance;
6. the impediments to a long examination with spectroscopy sequence of ten to twenty minutes: major tremors, inability to lie more than 30 minutes;
7. local sources of magnetic distortion which is sensitive spectroscopic imaging: hip replacement, prostate biopsy older than six weeks.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02516995
Study Brief:
Protocol Section:
NCT02516995